BioCentury
ARTICLE | Clinical News

VBY-036: Phase I started

June 3, 2013 7:00 AM UTC

Virobay began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate escalating doses of oral VBY-036 in 48 healthy volunteers. ...